O
OrbiMed Portfolio holdings
AUM
$3.98B
This Quarter Return
+17.87%
1 Year Return
+13.05%
3 Year Return
+159.74%
5 Year Return
+207.27%
10 Year Return
+1,027.33%
AUM
$5.42B
AUM Growth
+$5.42B
(+22%)
Cap. Flow
+$335M
Cap. Flow
% of AUM
6.18%
Top 10 Holdings %
Top 10 Hldgs %
41.42%
Holding
137
New
14
Increased
37
Reduced
30
Closed
15
Top Buys
| 1 |
Merck
MRK
|
$92.9M |
| 2 |
Bristol-Myers Squibb
BMY
|
$87.1M |
| 3 |
SHPG
Shire pic
SHPG
|
$82.8M |
| 4 |
CBST
CUBIST PHARMACEUTICALS INC
CBST
|
$51.7M |
| 5 |
Exelixis
EXEL
|
$50.9M |
Top Sells
| 1 |
ONXX
ONYX PHARMACEUTICALS INC
ONXX
|
$102M |
| 2 |
Incyte
INCY
|
$43.2M |
| 3 |
Acadia Pharmaceuticals
ACAD
|
$26.9M |
| 4 |
MAKO
MAKO SURGICAL CORP COM
MAKO
|
$26.7M |
| 5 |
Pfizer
PFE
|
$25.6M |
Sector Composition
| 1 | Healthcare | 86.37% |
| 2 | Financials | 1.83% |
| 3 | Technology | 0.15% |
| 4 | Utilities | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Medtronic
MDT
$118B
| $21.8M | 0.39% |
410,000
+217,700
| +113% | +$11.6M |
|
52
Bio-Techne
TECH
$8.3B
| $21.3M | 0.38% |
1,064,000
+720,000
| +209% | +$14.4M |
|
53
IQVIA
IQV
$31.4B
| $19.7M | 0.35% |
440,000
| – | – |
|
|
WCG
54
DELISTED
Wellcare Health Plans, Inc.
WCG
| $19M | 0.34% |
272,000
+39,000
| +17% | +$2.72M |
|
|
ATRS
55
DELISTED
Antares Pharma, Inc.
ATRS
| $17.7M | 0.32% |
4,365,000
-4,834,000
| -53% | -$19.6M |
|
|
MRTX
56
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $17.4M | 0.31% |
+1,149,332
| New | +$17.4M |
|
57
Cerus
CERS
$251M
| $17.2M | 0.31% |
+2,557,900
| New | +$17.2M |
|
|
RCPT
58
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
| $16.7M | 0.3% |
644,450
| – | – |
|
|
DRTX
59
DELISTED
DURATA THERAPEUTICS INC COM STK (DE)
DRTX
| $16.1M | 0.29% |
1,785,714
| – | – |
|
60
Bausch Health
BHC
$2.72B
| $14.4M | 0.26% |
138,000
| – | – |
|
61
Abbott
ABT
$230B
| $13.3M | 0.24% |
400,000
-80,000
| -17% | -$2.66M |
|
62
Xoma
XOMA
$421M
| $12.5M | 0.22% |
139,354
+10,058
| +8% | +$903K |
|
63
Community Health Systems
CYH
$392M
| $11.3M | 0.2% |
329,120
+36,300
| +12% | +$1.25M |
|
|
SVA
64
DELISTED
Sinovac Biotech, Ltd
SVA
| $11.3M | 0.2% |
1,884,200
| – | – |
|
|
MRGE
65
DELISTED
MERGE HEALTHCARE INC COM STK (WI)
MRGE
| $11.2M | 0.2% |
+4,296,000
| New | +$11.2M |
|
66
Baxter International
BAX
$12.1B
| $10.7M | 0.19% |
299,715
| – | – |
|
67
Dynavax Technologies
DVAX
$1.19B
| $10.7M | 0.19% |
898,600
| – | – |
|
|
ARQL
68
DELISTED
Arqule Inc
ARQL
| $10.2M | 0.18% |
4,366,000
+1,562,000
| +56% | +$3.64M |
|
69
Cardinal Health
CAH
$36B
| $9.87M | 0.18% |
189,300
| – | – |
|
70
McKesson
MCK
$85.9B
| $9.75M | 0.17% |
76,000
| – | – |
|
|
PTLA
71
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $8.75M | 0.16% |
327,000
-153,319
| -32% | -$4.1M |
|
72
Curis
CRIS
$21.5M
| $8.7M | 0.16% |
19,501
| – | – |
|
|
73
Acadia Pharmaceuticals
ACAD
$4.34B
| $8.57M | 0.15% |
312,000
-981,000
| -76% | -$26.9M |
|
|
VCRA
74
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
| $8.32M | 0.15% |
447,500
| – | – |
|
|
GEVA
75
DELISTED
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
| $8.24M | 0.15% |
+130,000
| New | +$8.24M |
|